Skip to main content

UroGen Pharma Ltd.

URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001668243

In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q3 2024

Institutional positions in UroGen Pharma Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
+14 vs. Q2 2024
Shares held
35.1M
−903.2K (−2.5%) vs. Q2 2024
Total value
$445.7M
−$158.9M (−26.3%) vs. Q2 2024
New holders
26
50 more added
Sold out
12
29 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting URGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 128 institutions
Q1 2021: 89 institutionsQ2 2021: 82 institutionsQ3 2021: 93 institutionsQ4 2021: 78 institutionsQ1 2022: 84 institutionsQ2 2022: 65 institutionsQ3 2022: 60 institutionsQ4 2022: 64 institutionsQ1 2023: 66 institutionsQ2 2023: 85 institutionsQ3 2023: 101 institutionsQ4 2023: 105 institutionsQ1 2024: 112 institutionsQ2 2024: 115 institutionsQ3 2024: 128 institutionsQ4 2024: 138 institutionsQ1 2025: 140 institutionsQ2 2025: 150 institutionsQ3 2025: 161 institutionsQ4 2025: 167 institutionsQ1 2026: 173 institutionsQ2 2026: 190 institutions
Value heldQ3 2024: $445.7M
Q1 2021: $278.5MQ2 2021: $213.7MQ3 2021: $236.9MQ4 2021: $140.4MQ1 2022: $123.9MQ2 2022: $109.2MQ3 2022: $110.8MQ4 2022: $115.4MQ1 2023: $116.1MQ2 2023: $137.8MQ3 2023: $248.3MQ4 2023: $321.2MQ1 2024: $407.4MQ2 2024: $641.4MQ3 2024: $445.7MQ4 2024: $386.3MQ1 2025: $460.6MQ2 2025: $545.2MQ3 2025: $878.6MQ4 2025: $1.02BQ1 2026: $835.2MQ2 2026: $1.56B
Institutions holding URGN and their total value by quarter
QuarterHoldersValue
Q2 2026190$1.56B
Q1 2026173$835.2M
Q4 2025167$1.02B
Q3 2025161$878.6M
Q2 2025150$545.2M
Q1 2025140$460.6M
Q4 2024138$386.3M
Q3 2024128$445.7M
Q2 2024115$641.4M
Q1 2024112$407.4M
Q4 2023105$321.2M
Q3 2023101$248.3M
Q2 202385$137.8M
Q1 202366$116.1M
Q4 202264$115.4M
Q3 202260$110.8M
Q2 202265$109.2M
Q1 202284$123.9M
Q4 202178$140.4M
Q3 202193$236.9M
Q2 202182$213.7M
Q1 202189$278.5M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding UroGen Pharma Ltd.; share changes are against Q2 2024.

Institutions holding URGN in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Rice Hall James & Associates, LLC271,897$3.45M0.19%+199,110+273.6%Added
Stonepine Capital Management, LLC280,345$3.56M2.25%+280,345New
Vanguard Group Inc284,437$3.61M0.00%+60,455+27.0%Added
Northern Trust Corp286,729$3.64M0.00%+69,367+31.9%Added
Woodline Partners LP305,642$3.88M0.03%+1,902+0.6%Added
Goldman Sachs Group Inc315,957$4.01M0.00%+52,351+19.9%Added
Parkman Healthcare Partners LLC347,541$4.41M0.56%+73,076+26.6%Added
Vestal Point Capital, LP400,000$5.08M0.40%+400,000New
Opaleye Management Inc.404,100$5.13M0.86%−7,900−1.9%Reduced
Geode Capital Management, LLC455,637$5.79M0.00%+34,248+8.1%Added
DAFNA Capital Management LLC458,915$5.83M1.38%−10,085−2.2%Reduced
Harel Insurance Investments & Financial Services Ltd.463,267$5.88M0.10%−298−0.1%Reduced
Wildcat Capital Management, LLC495,606$6.29M3.08%00.0%Unchanged
Migdal Insurance & Financial Holdings Ltd.686,472$8.72M0.14%00.0%Unchanged
Great Point Partners LLC758,786$9.64M2.91%−2,147,473−73.9%Reduced
State Street Corp769,583$9.77M0.00%+42,907+5.9%Added
Silverarc Capital Management, LLC901,129$11.4M2.58%−200,871−18.2%Reduced
Jefferies Financial Group Inc.965,000$12.3M0.20%00.0%Unchanged
UBS Asset Management Americas Inc1,341,072$17.0M0.00%+21,072+1.6%Added
Millennium Management LLC1,499,201$19.0M0.02%+338,302+29.1%Added
Point72 Asset Management, L.P.1,506,646$19.1M0.07%−942,631−38.5%Reduced
Cormorant Asset Management, LP1,550,000$19.7M1.04%−100,000−6.1%Reduced
Cowen and Company, LLC1,796,589$22.8M0.79%−302,893−14.4%Reduced
Morgan Stanley2,181,464$27.7M0.00%+342,758+18.6%Added
Menora Mivtachim Holdings Ltd.2,303,031$29.2M0.18%00.0%Unchanged
BlackRock, Inc.2,497,943$31.7M0.00%+2,497,943New
Adage Capital Partners GP, L.L.C.3,735,741$47.4M0.08%+435,741+13.2%Added
RTW Investments, LP3,787,347$48.1M0.70%+230,000+6.5%Added
Ra Capital Management, L.P.0$00.00%−3,083,430−100.0%Sold out
Laurion Capital Management LP0$00.00%−160,600−100.0%Sold out
Atom Investors LP0$00.00%−144,780−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−100,000−100.0%Sold out
Walleye Capital LLC0$00.00%−57,610−100.0%Sold out
Marshall Wace, LLP0$00.00%−42,841−100.0%Sold out
Oppenheimer & Co Inc0$00.00%−19,323−100.0%Sold out
ProShare Advisors LLC0$00.00%−11,888−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−10,843−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−5,298−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−87−100.0%Sold out
Toronto Dominion Bank0$00.00%−6−100.0%Sold out
BlackRock Inc.––––Not filed